NCT01794741

3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis

Randomized Trial of the Safety of Dymista Nasal Spray and Fluticasone Propionate Nasal Spray in Children Ages >4 Years to <12 Years With Allergic Rhinitis

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 405 (actual)
• Sponsor: Meda Pharmaceuticals · Industry
• Sex: All
• Age: 4 Years – 11 Years
• Healthy volunteers: Accepted

Summary

This is a 3 month safety study of Dymista Nasal spray in children aged 4 to 11 years with allergic rhinitis

Conditions

• Allergic Rhinitis

Interventions

Type	Name	Description
DRUG	Dymista Nasal Spray
DRUG	Fluticasone propionate nasal spray

Timeline

• Start date: 2013-02-01
• Primary completion: 2013-11-01
• First posted: 2013-02-20
• Last updated: 2015-03-31
• Results posted: 2015-03-31

Locations

41 sites across 1 country: United States